A phase II study of sunitinib in recurrent or metastatic endometrial carcinoma: A trial of the Princess Margaret Hospital, The University of Chicago, and California Cancer Phase II Consortia. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Correa, R
  • Mackay, H
  • Hirte, Holger
  • Morgan, R
  • Welch, S
  • Fleming, GF
  • Wang, L
  • Blattler, C
  • Ivy, SP
  • Oza, AM

publication date

  • May 20, 2010